GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

A team from the University of Geneva and Bayer AG present their findings on the on-off retention of oligonucleotides and the ...

Equities research analysts at StockNews.com assumed coverage on shares of Bio-Path (NASDAQ:BPTH – Get Free Report) in a report released on Wednesday. The firm set a “sell” rating on the stock.

Gene-silencing techniques, such as antisense-RNA targeting of essential phage-encoded genes (for example, DNA replication) can effectively inhibit the propagation of virulent phages. Trans ...

South San Francisco, CA, January 30, 2025 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, has awarded nearly ...

GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis ... hepatitis B surface antigen (HBsAg) and HBV DNA loss to below the limits of detection in 9% to ...

We read every piece of feedback, and take your input very seriously.

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities ...

HMGA overexpression impairs DNA repair. DNA repair systems are one of the best defences that the cell has to counteract carcinogenesis. Indeed, it is widely accepted that one of the crucial steps ...

LncRNAs function through playing multiple roles, including sponger for sequestering RNA or DNA, guider or decoy for recruiting or hijacking transcription factors or peptides, and scaffold for binding ...